On the fly News and insights, exclusive to thefly.com

FSLR

First Solar

$91.30 /

-2.14 (-2.29%)

, SWN

Southwestern Energy

$3.16 /

+0.05 (+1.61%)

09:54
12/01/20
12/01
09:54
12/01/20
09:54

Fly Intel: Top five analyst downgrades

Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. First Solar (FSLR) downgraded to Underweight from Equal Weight at Barclays with analyst Moses Sutton saying the company had positive exposure to a President Trump win, due to tariff extension potential. 2. Southwestern Energy (SWN) and Occidental Petroleum (OXY) downgraded to Sell from Neutral at UBS. 3. AB InBev (BUD) downgraded to Hold from Buy at Deutsche Bank with analyst Mitch Collett citing valuation. 4. Vail Resorts (MTN) downgraded to Market Perform from Outperform at William Blair with analyst Ryan Sundby saying with COVID-19 cases reaching new highs across the United States in recent weeks, there is an increased likelihood that the upcoming 2020/2021 ski season could be disrupted in a more meaningful way than previously anticipated. 5. Sage Therapeutics (SAGE) downgraded to Market Perform from Outperform at Raymond James with analyst Dane Leone after the company discussed the partnership between it and Biogen (BIIB), saying that Sage management failed to defend how the terms of the Biogen deal accelerate the earlier pipeline, and thinks Biogen management provided a relatively weak argument for their ability to build a presence within the field of psychiatry. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

FSLR

First Solar

$91.30 /

-2.14 (-2.29%)

SWN

Southwestern Energy

$3.16 /

+0.05 (+1.61%)

OXY

Occidental Petroleum

$16.13 /

+0.37 (+2.35%)

BUD

AB InBev

$67.31 /

+0.64 (+0.96%)

MTN

Vail Resorts

$272.77 /

-2.85 (-1.03%)

SAGE

Sage Therapeutics

$73.40 /

-0.68 (-0.92%)

  • 01

    Dec

  • 01

    Dec

  • 03

    Dec

  • 03

    Dec

  • 10

    Dec

  • 14

    Aug

  • 17

    Sep

FSLR First Solar
$91.30 /

-2.14 (-2.29%)

12/01/20 Barclays
First Solar downgraded to Underweight ahead of 'margin cliff' at Barclays
12/01/20 Barclays
First Solar downgraded to Underweight from Equal Weight at Barclays
11/10/20
Fly Intel: Top five analyst downgrades
11/10/20 Raymond James
Raymond James double downgrades First Solar to Underperform on Biden election
SWN Southwestern Energy
$3.16 /

+0.05 (+1.61%)

12/01/20 UBS
Southwestern Energy downgraded to Sell from Neutral at UBS
11/18/20
Fly Intel: Top five analyst initiations
11/18/20 Goldman Sachs
Southwestern Energy reinstated with a Buy at Goldman Sachs
10/21/20 Morgan Stanley
Cimarex, Diamondback could benefit from greater scale, says Morgan Stanley
OXY Occidental Petroleum
$16.13 /

+0.37 (+2.35%)

12/01/20 UBS
Occidental Petroleum downgraded to Sell from Neutral at UBS
11/20/20 Susquehanna
Occidental Petroleum upgraded to Positive from Neutral at Susquehanna
11/19/20 Scotiabank
Occidental Petroleum price target raised to $18 from $16 at Scotiabank
11/11/20
Fly Intel: Top five analyst downgrades
BUD AB InBev
$67.31 /

+0.64 (+0.96%)

12/01/20 Deutsche Bank
AB InBev downgraded to Hold from Buy at Deutsche Bank
11/27/20 Morgan Stanley
AB InBev price target raised to EUR 61 from EUR 44 at Morgan Stanley
11/12/20 Redburn
AB InBev downgraded to Neutral from Buy at Redburn
11/02/20 Deutsche Bank
AB InBev price target raised to EUR 59 from EUR 58 at Deutsche Bank
MTN Vail Resorts
$272.77 /

-2.85 (-1.03%)

12/01/20 William Blair
William Blair downgrades Vail Resorts on rise in Covid cases
12/01/20 William Blair
Vail Resorts downgraded to Market Perform from Outperform at William Blair
11/23/20 Janney Montgomery Scott
Vail Resorts downgraded to Neutral from Buy at Janney Montgomery Scott
11/12/20 Exane BNP Paribas
Vail Resorts initiated with an Outperform at Exane BNP Paribas
SAGE Sage Therapeutics
$73.40 /

-0.68 (-0.92%)

12/01/20 Truist
Sage Therapeutics price target raised to $70 from $60 at Truist
12/01/20 Raymond James
Sage Therapeutics downgraded to Market Perform from Outperform at Raymond James
12/01/20 Citi
Sage Therapeutics price target lowered to $93 from $100 at Citi
12/01/20 RBC Capital
Biogen price target raised to $256 from $249 at RBC Capital

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.